INMED PHARMACEUTICALS INC. Interest Income (Expense), Net
INMED PHARMACEUTICALS INC. (INM) reported Interest Income (Expense), Net of -$1.50 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2024-02-13
- INMED PHARMACEUTICALS INC. interest income (expense), net for the quarter ending 2023-03-31 was -$1.50K.
- INMED PHARMACEUTICALS INC. interest income (expense), net for the quarter ending 2022-12-31 was -$3.00K.
- INMED PHARMACEUTICALS INC. interest income (expense), net for the quarter ending 2022-09-30 was -$6.80K.
- INMED PHARMACEUTICALS INC. interest income (expense), net for the quarter ending 2021-06-30 was $0.00.
- INMED PHARMACEUTICALS INC. interest income (expense), net for fiscal 2021 was -$360.35K.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2023-03-31 | -$1.50K 10-Q · filed 2023-05-15 | -$4.50K derived: sum of 2 quarters · filed 2024-02-13 | -$11.30K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$3.00K 10-Q · filed 2024-02-13 | -$9.80K 10-Q · filed 2024-02-13 | ||
| 2022-09-30 | -$6.80K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-23 | $0.00 derived: sum of 2 quarters · filed 2022-09-23 | -$360.35K derived: sum of 3 quarters · filed 2022-09-23 | -$360.35K 10-K · filed 2022-09-23 |
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | -$360.35K derived: sum of 2 quarters · filed 2022-05-13 | -$360.35K 10-Q · filed 2022-05-13 | |
| 2020-12-31 | -$360.35K 10-Q · filed 2022-02-14 | -$360.35K 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |